Bcg Intravesical
PreclinicalSmall molecule
Bcg Intravesical is one of 5 small molecule programs targeting Ablation. It is currently in Preclinical.
1
Indications
1
Total Trials
1
Active Trials
4
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
6 competitors in Ablation
#DrugCompanyPhaseTrials
1Stadol
Bristol-Myers SquibbPreclinical
Guanidine Hydrochloride
Merck & Co.Preclinical
Perflutren Lipid Microsphere
IImaRx Therapeutics
Preclinical
Bcg Intravesical
HHuashan Hospital
Preclinical
Ajmaline
UUniversitair Ziekenhuis Brussel
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Bcg Intravesical. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- HHuashan Hospital